GINKGO BIOWORKS HOLDINGS INC's ticker is and the CUSIP is 37611X100. A total of 309 filers reported holding GINKGO BIOWORKS HOLDINGS INC in Q2 2024. The put-call ratio across all filers is 2.14 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $27,177 | -94.9% | 81,294 | -82.3% | 0.00% | – |
| Q1 2024 | $533,542 | -31.0% | 459,950 | +0.5% | 0.00% | – |
| Q4 2023 | $773,547 | +4.8% | 457,720 | +12.3% | 0.00% | – |
| Q3 2023 | $737,999 | -3.5% | 407,734 | -0.8% | 0.00% | – |
| Q2 2023 | $764,488 | +154.6% | 411,015 | +82.1% | 0.00% | – |
| Q1 2023 | $300,254 | -24.7% | 225,755 | -4.3% | 0.00% | – |
| Q4 2022 | $398,766 | -35.8% | 235,956 | +18.6% | 0.00% | – |
| Q3 2022 | $621,000 | +29.9% | 198,944 | -0.9% | 0.00% | – |
| Q2 2022 | $478,000 | – | 200,845 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PATHWAY CAPITAL MANAGEMENT, LP | 1,469,393 | $5,922,000 | 31.56% |
| Anchorage Capital Group, L.L.C. | 69,158,354 | $278,708,000 | 18.94% |
| Senator Investment Group LP | 46,015,343 | $175,955,000 | 5.46% |
| PLUSTICK MANAGEMENT LLC | 1,550,000 | $6,247,000 | 3.94% |
| Blue Water Life Science Advisors, LP | 1,781,684 | $7,180,000 | 3.41% |
| GENERAL ATLANTIC, L.P. | 90,810,814 | $365,968,000 | 3.35% |
| Trybe Capital Management LP | 1,207,992 | $4,868,000 | 2.03% |
| Kamunting Street Capital Management, L.P. | 400,000 | $1,612,000 | 2.01% |
| WASHINGTON UNIVERSITY | 1,102,044 | $4,441,000 | 1.60% |
| ALLEN OPERATIONS LLC | 2,248,996 | $9,063,000 | 1.60% |